Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: Possible involvement of PKC-MAPK signaling pathway

Vivian Soetikno, Flori R. Sari, Vijayakumar Sukumaran, Arun Lakshmanan, Sayaka Mito, Meilei Harima, Rajarajan A. Thandavarayan, Kenji Suzuki, Masaki Nagata, Ritsuo Takagi, Kenichi Watanabe

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

The development of diabetic cardiomyopathy is accompanied with a high membrane-bound protein kinase C (PKC) levels. Curcumin is a naturally occurring compound which is known to inhibit PKC activity. However, the effects of curcumin on ameliorating diabetic cardiomyopathy are still undefined. We evaluated whether curcumin treatment is associated with the modulation of PKC-α and -β2-mitogen-activated protein kinase (MAPK) pathway in experimental diabetic cardiomyopathy. Diabetes was induced in male Sprague-Dawley rats by streptozotocin (STZ). Curcumin (100 mg/kg/day) was started three weeks after STZ injection and was given for 8 weeks. We demonstrate that curcumin significantly prevented diabetes-induced translocation of PKC-α and -β2 to membranous fraction and diabetes-induced increased phosphorylation of p38MAPK and extracellular regulated-signal kinase (ERK)1/2 in left ventricular tissues of diabetic rats. Curcumin treatment also markedly decreased NAD(P)H oxidase subunits (p67phox, p22phox, gp91phox), growth factors (transforming growth factor-β, osteopontin) and myocyte enhancer factor-2 protein expression as well as inhibited NF-κB activity at nuclear level. Furthermore, curcumin decreased the mRNA expression of transcriptional coactivator p300 and atrial natriuretic peptide, decreased accumulation of ECM protein and reversed the increment of superoxide production in left ventricular tissues, as evidenced by dihydroethidium staining. It is also significantly lowered plasma glucose and attenuated oxidative stress, as determined by lipid peroxidation and activity of anti-oxidant enzyme, and as a result attenuated cardiomyocyte hypertrophy, myocardial fibrosis and left ventricular dysfunction. Taken together, it is suggested that curcumin by inhibiting PKC-α and -β2-MAPK pathway may be useful as an adjuvant therapy for the prevention of diabetic cardiomyopathy.

Original languageEnglish
Pages (from-to)604-614
Number of pages11
JournalEuropean Journal of Pharmaceutical Sciences
Volume47
Issue number3
DOIs
Publication statusPublished - 9 Oct 2012
Externally publishedYes

Fingerprint

Diabetic Cardiomyopathies
Curcumin
Streptozocin
Mitogen-Activated Protein Kinases
Protein Kinase C
Mitogen-Activated Protein Kinase 1
MEF2 Transcription Factors
Osteopontin
Mitogen-Activated Protein Kinase 3
NADPH Oxidase
Left Ventricular Dysfunction
Transforming Growth Factors
Atrial Natriuretic Factor
Cardiac Myocytes
Oxidants
Superoxides
Hypertrophy
Lipid Peroxidation
Sprague Dawley Rats
Intercellular Signaling Peptides and Proteins

Keywords

  • Curcumin
  • Diabetic cardiomyopathy
  • Mitogen-activated protein kinase
  • Protein kinase C

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats : Possible involvement of PKC-MAPK signaling pathway. / Soetikno, Vivian; Sari, Flori R.; Sukumaran, Vijayakumar; Lakshmanan, Arun; Mito, Sayaka; Harima, Meilei; Thandavarayan, Rajarajan A.; Suzuki, Kenji; Nagata, Masaki; Takagi, Ritsuo; Watanabe, Kenichi.

In: European Journal of Pharmaceutical Sciences, Vol. 47, No. 3, 09.10.2012, p. 604-614.

Research output: Contribution to journalArticle

Soetikno, V, Sari, FR, Sukumaran, V, Lakshmanan, A, Mito, S, Harima, M, Thandavarayan, RA, Suzuki, K, Nagata, M, Takagi, R & Watanabe, K 2012, 'Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: Possible involvement of PKC-MAPK signaling pathway', European Journal of Pharmaceutical Sciences, vol. 47, no. 3, pp. 604-614. https://doi.org/10.1016/j.ejps.2012.04.018
Soetikno, Vivian ; Sari, Flori R. ; Sukumaran, Vijayakumar ; Lakshmanan, Arun ; Mito, Sayaka ; Harima, Meilei ; Thandavarayan, Rajarajan A. ; Suzuki, Kenji ; Nagata, Masaki ; Takagi, Ritsuo ; Watanabe, Kenichi. / Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats : Possible involvement of PKC-MAPK signaling pathway. In: European Journal of Pharmaceutical Sciences. 2012 ; Vol. 47, No. 3. pp. 604-614.
@article{cc3018670ebf45faa3e88009fb4b32ec,
title = "Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: Possible involvement of PKC-MAPK signaling pathway",
abstract = "The development of diabetic cardiomyopathy is accompanied with a high membrane-bound protein kinase C (PKC) levels. Curcumin is a naturally occurring compound which is known to inhibit PKC activity. However, the effects of curcumin on ameliorating diabetic cardiomyopathy are still undefined. We evaluated whether curcumin treatment is associated with the modulation of PKC-α and -β2-mitogen-activated protein kinase (MAPK) pathway in experimental diabetic cardiomyopathy. Diabetes was induced in male Sprague-Dawley rats by streptozotocin (STZ). Curcumin (100 mg/kg/day) was started three weeks after STZ injection and was given for 8 weeks. We demonstrate that curcumin significantly prevented diabetes-induced translocation of PKC-α and -β2 to membranous fraction and diabetes-induced increased phosphorylation of p38MAPK and extracellular regulated-signal kinase (ERK)1/2 in left ventricular tissues of diabetic rats. Curcumin treatment also markedly decreased NAD(P)H oxidase subunits (p67phox, p22phox, gp91phox), growth factors (transforming growth factor-β, osteopontin) and myocyte enhancer factor-2 protein expression as well as inhibited NF-κB activity at nuclear level. Furthermore, curcumin decreased the mRNA expression of transcriptional coactivator p300 and atrial natriuretic peptide, decreased accumulation of ECM protein and reversed the increment of superoxide production in left ventricular tissues, as evidenced by dihydroethidium staining. It is also significantly lowered plasma glucose and attenuated oxidative stress, as determined by lipid peroxidation and activity of anti-oxidant enzyme, and as a result attenuated cardiomyocyte hypertrophy, myocardial fibrosis and left ventricular dysfunction. Taken together, it is suggested that curcumin by inhibiting PKC-α and -β2-MAPK pathway may be useful as an adjuvant therapy for the prevention of diabetic cardiomyopathy.",
keywords = "Curcumin, Diabetic cardiomyopathy, Mitogen-activated protein kinase, Protein kinase C",
author = "Vivian Soetikno and Sari, {Flori R.} and Vijayakumar Sukumaran and Arun Lakshmanan and Sayaka Mito and Meilei Harima and Thandavarayan, {Rajarajan A.} and Kenji Suzuki and Masaki Nagata and Ritsuo Takagi and Kenichi Watanabe",
year = "2012",
month = "10",
day = "9",
doi = "10.1016/j.ejps.2012.04.018",
language = "English",
volume = "47",
pages = "604--614",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats

T2 - Possible involvement of PKC-MAPK signaling pathway

AU - Soetikno, Vivian

AU - Sari, Flori R.

AU - Sukumaran, Vijayakumar

AU - Lakshmanan, Arun

AU - Mito, Sayaka

AU - Harima, Meilei

AU - Thandavarayan, Rajarajan A.

AU - Suzuki, Kenji

AU - Nagata, Masaki

AU - Takagi, Ritsuo

AU - Watanabe, Kenichi

PY - 2012/10/9

Y1 - 2012/10/9

N2 - The development of diabetic cardiomyopathy is accompanied with a high membrane-bound protein kinase C (PKC) levels. Curcumin is a naturally occurring compound which is known to inhibit PKC activity. However, the effects of curcumin on ameliorating diabetic cardiomyopathy are still undefined. We evaluated whether curcumin treatment is associated with the modulation of PKC-α and -β2-mitogen-activated protein kinase (MAPK) pathway in experimental diabetic cardiomyopathy. Diabetes was induced in male Sprague-Dawley rats by streptozotocin (STZ). Curcumin (100 mg/kg/day) was started three weeks after STZ injection and was given for 8 weeks. We demonstrate that curcumin significantly prevented diabetes-induced translocation of PKC-α and -β2 to membranous fraction and diabetes-induced increased phosphorylation of p38MAPK and extracellular regulated-signal kinase (ERK)1/2 in left ventricular tissues of diabetic rats. Curcumin treatment also markedly decreased NAD(P)H oxidase subunits (p67phox, p22phox, gp91phox), growth factors (transforming growth factor-β, osteopontin) and myocyte enhancer factor-2 protein expression as well as inhibited NF-κB activity at nuclear level. Furthermore, curcumin decreased the mRNA expression of transcriptional coactivator p300 and atrial natriuretic peptide, decreased accumulation of ECM protein and reversed the increment of superoxide production in left ventricular tissues, as evidenced by dihydroethidium staining. It is also significantly lowered plasma glucose and attenuated oxidative stress, as determined by lipid peroxidation and activity of anti-oxidant enzyme, and as a result attenuated cardiomyocyte hypertrophy, myocardial fibrosis and left ventricular dysfunction. Taken together, it is suggested that curcumin by inhibiting PKC-α and -β2-MAPK pathway may be useful as an adjuvant therapy for the prevention of diabetic cardiomyopathy.

AB - The development of diabetic cardiomyopathy is accompanied with a high membrane-bound protein kinase C (PKC) levels. Curcumin is a naturally occurring compound which is known to inhibit PKC activity. However, the effects of curcumin on ameliorating diabetic cardiomyopathy are still undefined. We evaluated whether curcumin treatment is associated with the modulation of PKC-α and -β2-mitogen-activated protein kinase (MAPK) pathway in experimental diabetic cardiomyopathy. Diabetes was induced in male Sprague-Dawley rats by streptozotocin (STZ). Curcumin (100 mg/kg/day) was started three weeks after STZ injection and was given for 8 weeks. We demonstrate that curcumin significantly prevented diabetes-induced translocation of PKC-α and -β2 to membranous fraction and diabetes-induced increased phosphorylation of p38MAPK and extracellular regulated-signal kinase (ERK)1/2 in left ventricular tissues of diabetic rats. Curcumin treatment also markedly decreased NAD(P)H oxidase subunits (p67phox, p22phox, gp91phox), growth factors (transforming growth factor-β, osteopontin) and myocyte enhancer factor-2 protein expression as well as inhibited NF-κB activity at nuclear level. Furthermore, curcumin decreased the mRNA expression of transcriptional coactivator p300 and atrial natriuretic peptide, decreased accumulation of ECM protein and reversed the increment of superoxide production in left ventricular tissues, as evidenced by dihydroethidium staining. It is also significantly lowered plasma glucose and attenuated oxidative stress, as determined by lipid peroxidation and activity of anti-oxidant enzyme, and as a result attenuated cardiomyocyte hypertrophy, myocardial fibrosis and left ventricular dysfunction. Taken together, it is suggested that curcumin by inhibiting PKC-α and -β2-MAPK pathway may be useful as an adjuvant therapy for the prevention of diabetic cardiomyopathy.

KW - Curcumin

KW - Diabetic cardiomyopathy

KW - Mitogen-activated protein kinase

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=84865516853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865516853&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2012.04.018

DO - 10.1016/j.ejps.2012.04.018

M3 - Article

C2 - 22564708

AN - SCOPUS:84865516853

VL - 47

SP - 604

EP - 614

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

IS - 3

ER -